Compare HCA Health Inc (HCA) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Liberty Global Ltd Class C — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.06B). The key difference: HCA Health Inc is far larger — about 31.5× Liberty Global Ltd Class C's market cap, and HCA Health Inc pays a 0.7% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Liberty Global Ltd Class C for 21 Days on average.
| HCA | LBTYK | |
|---|---|---|
Market Cap | $96.35B | $3.06B |
Volume | 1,079,453 | 2,508,956 |
Sector | Health | Media |
52-Week High | $545.13 | $12.67 |
52-Week Low | $361.32 | $8.75 |
Typical Hold Time | 76 Days | 21 Days |
Enterprise Value | $146.88B | $9.72B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
Liberty Global (LBTYK) trades at $8.92, down 0.28% on the day and near 52-week lows. The stock shows bearish technical signals with mixed quarterly earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Despite negative profitability metrics (-62.14% net margin), the company maintains strong operating cash flow of $1.21B and trades at discounted valuations with P/S of 0.61 and P/B of 0.32. Recent developments include the VodafoneZiggo acquisition completion and AI partnership with Sierra.
The investment case hinges on the 2027 Ziggo Group spin-off unlocking value, supported by analyst consensus price target of $12.67 (42% upside). However, persistent net losses and bearish technical momentum present significant risks. The stock offers speculative appeal for investors betting on management's restructuring success, but requires careful risk management given ongoing profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
